{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:57:59Z","timestamp":1792429079892,"version":"4.5.0"},"reference-count":91,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicol. Sci."],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1093\/toxsci\/kfv181","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T12:27:19Z","timestamp":1445776039000},"page":"14-25","source":"Crossref","is-referenced-by-count":93,"title":["Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence"],"prefix":"10.1093","volume":"148","author":[{"given":"Edward J.","family":"Perkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Antczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyle","family":"Burgoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Falciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e0lia","family":"Garcia-Reyero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Gutsell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoff","family":"Hodges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Kienzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dries","family":"Knapen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,10,25]]},"reference":[{"key":"2016080102545293000_148.1.14.1","doi-asserted-by":"publisher","DOI":"10.1002\/etc.34"},{"key":"2016080102545293000_148.1.14.2","doi-asserted-by":"publisher","DOI":"10.1002\/etc.2708"},{"key":"2016080102545293000_148.1.14.3","doi-asserted-by":"publisher","DOI":"10.1021\/acs.est.5b02707"},{"key":"2016080102545293000_148.1.14.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2007.10.008"},{"key":"2016080102545293000_148.1.14.5","doi-asserted-by":"publisher","DOI":"10.1002\/etc.5620200418"},{"key":"2016080102545293000_148.1.14.6","doi-asserted-by":"publisher","DOI":"10.1080\/1062936X.2013.871577"},{"key":"2016080102545293000_148.1.14.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.04.004"},{"key":"2016080102545293000_148.1.14.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020887"},{"key":"2016080102545293000_148.1.14.9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00216.2007"},{"key":"2016080102545293000_148.1.14.10","doi-asserted-by":"publisher","DOI":"10.1080\/10408440600977677"},{"key":"2016080102545293000_148.1.14.11","doi-asserted-by":"publisher","DOI":"10.1080\/10408440701749421"},{"key":"2016080102545293000_148.1.14.12","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kft067"},{"key":"2016080102545293000_148.1.14.13","doi-asserted-by":"publisher","DOI":"10.1002\/etc.2301"},{"key":"2016080102545293000_148.1.14.14","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.1104870"},{"key":"2016080102545293000_148.1.14.15","doi-asserted-by":"publisher","DOI":"10.1021\/es201095r"},{"key":"2016080102545293000_148.1.14.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2011.08.050"},{"key":"2016080102545293000_148.1.14.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.01.011"},{"key":"2016080102545293000_148.1.14.18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21802"},{"key":"2016080102545293000_148.1.14.19","doi-asserted-by":"publisher","DOI":"10.1007\/s00027-002-8052-2"},{"key":"2016080102545293000_148.1.14.20","first-page":"1","article-title":"Regulation (EC) No 1907\/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency","volume":"396","author":"European Parliament.","year":"2006","journal-title":"O. J. Eur. Union"},{"key":"2016080102545293000_148.1.14.21","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12075"},{"key":"2016080102545293000_148.1.14.22","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1161(91)90130-Z"},{"key":"2016080102545293000_148.1.14.23","doi-asserted-by":"publisher","DOI":"10.1021\/es504976d"},{"key":"2016080102545293000_148.1.14.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymeth.2006.07.006"},{"key":"2016080102545293000_148.1.14.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2014.09.068"},{"key":"2016080102545293000_148.1.14.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2014.10.006"},{"key":"2016080102545293000_148.1.14.27","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-010-0396-x"},{"key":"2016080102545293000_148.1.14.28","first-page":"295","article-title":"The environment and disease: Association or causation","volume":"58","author":"Hill","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"2016080102545293000_148.1.14.29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/jat.2869","article-title":"Bayesian integrated testing strategy to assess skin sensitization potency: From theory to practice","volume":"11","author":"Jaworska","year":"2013","journal-title":"J. Appl. Toxicol."},{"key":"2016080102545293000_148.1.14.30","unstructured":"JBRC, Japan Bioassay Research Center. (1998). Two-year studies of 1,4-dioxane in F344 rats and BDF1 mice (drinking water). Technical report of the Japan Bioassay Research Center, Kanagawa, Japan."},{"key":"2016080102545293000_148.1.14.31","doi-asserted-by":"publisher","DOI":"10.1021\/tx100428e"},{"key":"2016080102545293000_148.1.14.32","doi-asserted-by":"publisher","DOI":"10.1080\/10408390903110692"},{"key":"2016080102545293000_148.1.14.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2009.08.012"},{"key":"2016080102545293000_148.1.14.34","doi-asserted-by":"publisher","DOI":"10.1080\/08958370802629610"},{"key":"2016080102545293000_148.1.14.35","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.6324"},{"key":"2016080102545293000_148.1.14.36","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-007-0006-6"},{"key":"2016080102545293000_148.1.14.37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00278640"},{"key":"2016080102545293000_148.1.14.38","doi-asserted-by":"publisher","DOI":"10.2307\/3428124"},{"key":"2016080102545293000_148.1.14.39","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2914"},{"key":"2016080102545293000_148.1.14.40","doi-asserted-by":"publisher","DOI":"10.1016\/0041-008X(74)90099-4"},{"key":"2016080102545293000_148.1.14.41","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/etc.375","article-title":"Adverse outcome pathways and ecological risk assessment: Bridging to population-level effects","volume":"30","author":"Kramer","year":"2010","journal-title":"Environ. Toxicol. Chem."},{"key":"2016080102545293000_148.1.14.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2009.03.008"},{"key":"2016080102545293000_148.1.14.43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14573\/altex.1309261","article-title":"t4 workshop report: Pathways of Toxicity","volume":"31","author":"Kleensang","year":"2013","journal-title":"ALTEX."},{"key":"2016080102545293000_148.1.14.44","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1412231"},{"key":"2016080102545293000_148.1.14.45","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(87)90099-1"},{"key":"2016080102545293000_148.1.14.46","doi-asserted-by":"publisher","DOI":"10.1080\/10629360902949153"},{"key":"2016080102545293000_148.1.14.47","doi-asserted-by":"publisher","DOI":"10.14573\/altex.2013.4.473"},{"key":"2016080102545293000_148.1.14.48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4137\/CIN.S3229","article-title":"Discrimination of carcinogens by hepatic transcript profiling in rats following 28-day administration","volume":"7","author":"Matsumoto","year":"2009","journal-title":"Cancer Inform."},{"key":"2016080102545293000_148.1.14.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2013.10.013"},{"key":"2016080102545293000_148.1.14.50","doi-asserted-by":"publisher","DOI":"10.1002\/jat.2949"},{"key":"2016080102545293000_148.1.14.51","doi-asserted-by":"publisher","DOI":"10.1897\/06-318R.1"},{"key":"2016080102545293000_148.1.14.52","doi-asserted-by":"publisher","DOI":"10.1159\/000342405"},{"key":"2016080102545293000_148.1.14.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-004-0590-z"},{"key":"2016080102545293000_148.1.14.54","unstructured":"NCI, National Cancer Institute. (1978). Bioassay of 1,4-dioxane for possible carcinogenicity. (78-1330 NCICGTR-80). Bethesda, MD. Available at: http:\/\/ntp.niehs.nih.gov\/ntp\/htdocs\/LT_rpts\/tr080.pdf. Accessed January 25, 2015."},{"key":"2016080102545293000_148.1.14.55","unstructured":"NRC, National Research Council US Committee on Toxicity. (2007). Toxicity Testing in the 21st Century. Washington, DC, The National Academies Press."},{"key":"2016080102545293000_148.1.14.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.tiv.2012.11.006"},{"key":"2016080102545293000_148.1.14.57","unstructured":"OECD, Organization for Economic Cooperation and Development. (2009a). Report of the Expert Consultation to Evaluate an Estrogen Receptor Binding Affinity Model for Hazard Identification. OECD, Environment Directorate, Joint Meeting of the Chemicals Committee and the Working Party on Chemicals, Pesticides and Biotechnology. Available at: http:\/\/search.oecd.org\/officialdocuments\/displaydocumentpdf\/?cote=env\/jm\/mono(2009)33&doclanguage=en. Accessed January 25, 2015."},{"key":"2016080102545293000_148.1.14.58","unstructured":"OECD, Organization for Economic Co-operation and Development. (2009b). Guidance document for using the OECD (Q)SAR application toolbox to develop chemical categories according to the OECD guidance on grouping of chemicals. OECD Series on Testing and Assessment Number 102. Paris, France."},{"key":"2016080102545293000_148.1.14.59","unstructured":"OECD, Organization for Economic Co-operation and Development. (2012). Series on Testing and Assessment No. 168 ENV\/JM\/MONO(2012)10\/PART1 The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins. Paris, France."},{"key":"2016080102545293000_148.1.14.60","unstructured":"OECD, Organisation for Economic Co-operation and Development. (2013a). Guidance document on developing and assessing adverse outcome pathways. Series on testing and assessment, No. 184. Paris, France. Available at: http:\/\/search.oecd.org\/officialdocuments\/displaydocumentpdf\/?cote=env\/jm\/mono(2013)6&doclanguage=en. Accessed May 20, 2015."},{"key":"2016080102545293000_148.1.14.61","unstructured":"OECD, Organisation for Economic Co-operation and Development. (2013b). Users\u2019 handbook supplement to the guidance document for developing and assessing AOPs. Available at: https:\/\/aopkb.org\/common\/AOP_Handbook.pdf. Accessed May 20, 2015."},{"key":"2016080102545293000_148.1.14.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.02.011"},{"key":"2016080102545293000_148.1.14.63","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1310151"},{"key":"2016080102545293000_148.1.14.64","doi-asserted-by":"publisher","DOI":"10.1021\/tx100420w"},{"key":"2016080102545293000_148.1.14.65","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1289\/ehp.1205065","article-title":"Using in vitro high throughput screening assays to identify potential endocrine-disrupting chemicals","volume":"121","author":"Rotroff","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"2016080102545293000_148.1.14.66","doi-asserted-by":"publisher","DOI":"10.14573\/altex.1506201"},{"key":"2016080102545293000_148.1.14.67","doi-asserted-by":"publisher","DOI":"10.1897\/1551-5028(1997)016<0948:PMOTAF>2.3.CO;2"},{"key":"2016080102545293000_148.1.14.68","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2008.05.002"},{"key":"2016080102545293000_148.1.14.69","unstructured":"Schmitt C. J. Dethloff G. M. (2000). Biomonitoring of Environmental Status and Trends (BEST) Program: Selected methods for monitoring chemical contaminants and their effects in aquatic ecosystems. U.S. Geological Survey, Biological Resources Division, Columbia, (MO): Information and Technology Report USGS\/BRD (2000) 0005 . 81 p."},{"key":"2016080102545293000_148.1.14.70","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-4-89"},{"key":"2016080102545293000_148.1.14.71","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-15-3-342"},{"key":"2016080102545293000_148.1.14.72","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.2001.1493"},{"key":"2016080102545293000_148.1.14.73","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.5307"},{"key":"2016080102545293000_148.1.14.74","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.09.009"},{"key":"2016080102545293000_148.1.14.75","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)00524-4"},{"key":"2016080102545293000_148.1.14.76","unstructured":"USEPA, United States Environmental Protection Agency. (1998). EDSTAC: Endocrine disruptor screening and testing advisory committee final report U.S. Environmental Protection Agency. Available at: http:\/\/www.epa.gov\/endo\/pubs\/edspoverview\/finalrpt.htm. Accessed May 18, 2015."},{"key":"2016080102545293000_148.1.14.77","unstructured":"USEPA, U.S. Environmental Protection Agency. (2005). Guidelines for Carcinogen Risk Assessment. EPA\/630\/P-03\/001F. Risk Assessment Forum. Washington, DC. Available at: http:\/\/www.epa.gov\/ttnatw01\/cancer_guidelines_final_3-25-05.pdf. Accessed May 15, 2015."},{"key":"2016080102545293000_148.1.14.78","unstructured":"USEPA, United States Environmental Protection Agency. (2009). ECOSARTM . Office of Pollution and Toxic Substances, Washington, DC."},{"key":"2016080102545293000_148.1.14.79","unstructured":"USEPA, United States Environmental Protection Agency. (2011). Endocrine Disruptor Screening Program, Weight of Evidence: Results of EDSP Tier 1 Screening to Identify the Need for Tier 2 Testing. Available at: http:\/\/www.regulations.gov\/#!documentDetail;D=EPA-HQ-OPPT-2010-0877-0021. Accessed May 20, 2015."},{"key":"2016080102545293000_148.1.14.80","unstructured":"USEPA, United States Environmental Protection Agency. (2012). Prioritization of the Endocrine Disruptor Screening Program Universe of Chemicals for an Estrogen Receptor Adverse Outcome Pathway Using Computational Toxicology Tools. Availabel at: http:\/\/www.epa.gov\/endo\/pubs\/edsp_chemical_universe_and_general_validations_white_paper_11_12.pdf. Accessed May 10, 2015."},{"key":"2016080102545293000_148.1.14.81","unstructured":"USEPA, United State Environmental Protection Agency. (2013). Toxicological review of 1,4-Dioxane (with inhalation update) (CAS No. 123-91-1) in support of summary information on the Integrated Risk Information System (IRIS), Report EPA-635\/R-11\/003-F. US Environmental Protection Agency. Washington, DC."},{"key":"2016080102545293000_148.1.14.82","doi-asserted-by":"publisher","DOI":"10.3109\/10408444.2014.925425"},{"key":"2016080102545293000_148.1.14.83","doi-asserted-by":"publisher","DOI":"10.3109\/10408449509089890"},{"key":"2016080102545293000_148.1.14.84","doi-asserted-by":"publisher","DOI":"10.1139\/f83-096"},{"key":"2016080102545293000_148.1.14.85","doi-asserted-by":"publisher","DOI":"10.1016\/0045-6535(92)90280-5"},{"key":"2016080102545293000_148.1.14.86","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfu199"},{"key":"2016080102545293000_148.1.14.87","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfu200"},{"key":"2016080102545293000_148.1.14.88","doi-asserted-by":"publisher","DOI":"10.1002\/etc.2403"},{"key":"2016080102545293000_148.1.14.89","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfr185"},{"key":"2016080102545293000_148.1.14.90","doi-asserted-by":"crossref","unstructured":"Willett C. Rae J. C. Goyak K. O. Landesmann B. (2014). Pathway-based toxicity: History, current approaches and liver fibrosis and steatosis as prototypes. ALTEX. Available at: http:\/\/dx.doi.org\/10.14573\/altex.1401283. Accessed May 15, 2015.","DOI":"10.14573\/altex.1401283"},{"key":"2016080102545293000_148.1.14.91","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-154"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/toxsci\/article-pdf\/148\/1\/14\/4672960\/kfv181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T20:29:26Z","timestamp":1718137766000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article-lookup\/doi\/10.1093\/toxsci\/kfv181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,10,25]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.1093\/toxsci\/kfv181"],"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfv181","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"value":"1096-6080","type":"print"},{"value":"1096-0929","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,25]]}}}